SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)
RIGL 35.20-2.6%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject2/13/2002 7:57:46 PM
From: mopgcw  Read Replies (1) of 566
 
Alta BioPharma Buys 1.2M Rigel Pharmaceuticals Shares

DOW JONES NEWSWIRES

WASHINGTON -- Alta BioPharma Partners II LP purchased 1.2 million Rigel Pharmaceuticals Inc. (RIGL) common shares in January, according to a Form 4 released Wednesday by the Securities and Exchange Commission.

Jean Deleage, a director of Rigel Pharmaceuticals, is associated with Alta BioPharma.

Alta BioPharma bought the shares on Jan. 16 for $4.50 apiece. At the end of the month, Alta BioPharma owned 5.8 million Rigel Pharmaceuticals common shares.

Shares of Rigel Pharmaceuticals, of San Francisco, closed Wednesday up 3 cents to $4.44.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext